Latest biotechnology News | Page 2

Telix says strong revenue growth underpins investment in late-stage pipeline
Dimerix announces successful collection of data for first patients in ACTION3 trial
MinterEllison advises Aravax on US$68 million raising for peanut allergy therapy
LBT Innovations confirms deliver of APAS PharmaQC to Thermo Fisher
IVDs used in FMT screening exempt from Class 4 IVD requirement
Potato plant radiation sensors could one day monitor radiation in areas surrounding power plants
Certa Therapeutics’ FT011 granted US FDA fast track for systemic sclerosis
Inaugural AusMedtechInvest 2024 launched
CSIRO launches free SME programme for medtech and digital health companies
Syntara launches new blood cancer trial of lead candidate
Opthea completes enrolment in first pivotal trial with sozinibercept
Brandon BioCatalyst, in partnership with ANDHealth, selected by Federal Government to deliver $50m Dementia and Cognitive Decline Incubator
Studies made easier with bursaries
CSL reports strong first half growth with immunoglobulins the highlight
Immuron reports record sales of Travelan immune supplement
NSW Women in Life Sciences Luncheon 2024 speakers announced
Game changing gene therapies focus of £14m research hub
Cochlear upgrades earnings guidance on better than expected implant revenue
First patient receives treatment in Chimeric’s trial of CHM 0201 in AML
Competition opens to elevate early-stage medtech pitches
Deflexifol clinical data presented at ASCO Gastrointestinal Cancers Symposium
Sustainable funding sought for National One Stop Shop for clinical trials
Cell & Gene Catalyst working groups members announced
Better treatments sooner – Hudson’s new RNAte Platform unveiled
Investing In World-First Tech For Vaccine Development
Close look at Australia’s soil profiles
Starpharma says Viraleze shows antiviral efficacy in COVID-19 patients
Arovella licences novel CARiNKT cell armouring technology
Pioneering melanoma researchers named 2024 Australian of the Year
AusBiotech members invited to capital attraction roundtable
Aravax closes funding round to accelerate development for peanut allergy therapy
Investing in ground breaking peanut allergy therapy
AVITA Medical signs US distribution agreement with Stedical Scientific
Opthea receives additional funding under development funding agreement
Chimeric Therapeutics completes placement with shortfall commitments
Hidden threat: the rise of deadly fungal pathogens
Made In Victoria: Groundbreaking Peanut Allergy Therapy
Hidden threat: rise of deadly fungal pathogens
A novel switch to turn genes on/off, promising step toward safer gene therapy
ChemPartner Unveils Highly Anticipated Biology Database
A year of Science and Engineering at The University of Manchester
Carina Biotech doses first patient in Phase 1/2a trial of LGR5-Targeted CAR-T cell therapy
Neuren Pharmaceuticals announces top-line results of Phase 2 NNZ-2591 trial
Year of collective success: 2023 in review
AusBiotech announces Acting CEO
Eggs from men, sperm from women: how stem cell science may change how we reproduce
CMAX Clinical Research preparing to celebrate three decades of continuous operations
Brooker Consulting launches two new initiative for life science sector